previous
demonstr
gener
measl
viru
mv
specif
cytotox
ctl
reduc
patient
multipl
sclerosi
ms
contrast
ctl
specif
influenza
viru
flu
mump
viru
normal
uncertain
reduc
ctl
limit
mv
ms
patient
reduc
ctl
may
found
virus
well
sinc
mvspecif
ctl
predominantli
restrict
hla
class
ii
molecul
fluspecif
mumpsspecif
ctl
larg
hla
class
irestrict
compon
reduc
mvspecif
ctl
may
reflect
broader
reduct
hla
class
iirestrict
ctl
patient
ms
examin
question
studi
gener
ctl
specif
herp
simplex
viru
type
hsv
hsvspecif
ctl
like
mvspecif
ctl
predominantli
restrict
hla
class
ii
molecul
found
patient
ms
reduc
gener
ctl
mv
hsv
patient
reduc
gener
ctl
one
viru
also
similar
impair
respect
second
viru
patient
howev
reduct
gener
ctl
mv
hsv
find
extend
earlier
observ
regard
reduc
mvspecif
ctl
patient
ms
second
hla
class
iirestrict
viru
hsv
reduct
may
reflect
discret
impair
immun
function
separ
virus
possibl
associ
viral
persist
may
reflect
gener
defect
hla
class
iirestrict
ctl
previou
studi
patient
multipl
sclerosi
ms
shown
reduc
gener
measl
viru
mv
specif
cytotox
ctl
compar
normal
neurolog
diseas
control
jacobson
et
al
appear
result
decreas
precursor
frequenc
mvsensit
effector
rather
suppress
mvspecif
ctl
immunoregulatori
cell
mcfarland
et
al
contrast
ctl
respons
relat
paramyxoviru
mump
viru
anoth
rna
base
viru
influenza
viru
normal
ms
patient
jacobson
et
al
goodman
et
al
suggest
impair
virusspecif
ctl
seen
ms
patient
may
limit
mv
mvrelat
immun
uniqu
affect
ms
observ
may
reflect
abnorm
infect
mv
similar
impair
gener
mvspecif
ctl
report
patient
subacut
scleros
panenceph
disord
known
result
persist
infect
mv
dhibjalbut
et
al
altern
explan
reduc
mvspecif
ctl
found
reflect
gener
immunolog
abnorm
ms
abnorm
might
involv
either
impair
immun
multipl
virus
insofar
mvspecif
ctl
predominantli
restrict
hla
class
ii
molecul
jacobson
et
al
reduct
ctl
mediat
tcell
mumpsspecif
ctl
well
influenza
viru
flu
specif
ctl
larg
hla
class
irestrict
compon
rotteveel
et
ai
goodman
et
al
hla
class
irestrict
ctl
thought
predominantli
mediat
tcell
studi
extend
investig
virusspecif
ctl
ms
patient
herp
simplex
viru
type
hsv
hsv
although
unrel
mv
result
viral
persist
ctl
direct
hsv
like
mvspecif
ctl
thought
predominantli
restrict
hla
class
ii
molecul
yasukawa
zarl
b
sixteen
patient
chronic
progress
multipl
sclerosi
examin
clinic
healthi
control
recruit
nih
blood
bank
underw
lymphocytapheresi
studi
review
institut
review
board
inform
consent
obtain
prior
evalu
procedur
ms
patient
taken
popul
patient
receiv
placebo
earlier
clinic
trim
multipl
sclerosi
studi
group
patient
immunosuppress
medic
time
lymphocytapheresi
receiv
medic
within
month
procedur
patient
edss
score
rang
kurtzk
ms
patient
signific
level
virusspecif
antibodi
mv
hsv
indic
prior
scnsitiz
virus
signific
differ
ms
patient
control
either
age
sex
mean
age
control
popul
sd
ms
popul
sd
femal
male
ratio
control
group
ms
group
peripher
blood
lymphocyt
pbl
obtain
patient
normal
donor
lymphocytapheresi
serum
obtain
direct
venipunctur
pbl
purifi
densiti
gradient
centrifug
frozen
cryopreserv
medium
human
serum
maintain
liquid
nitrogen
vapor
freezer
need
mv
edmonston
strain
hsv
atcc
viru
pool
prepar
harvest
cultur
supernat
virusinfect
vero
cell
describ
elsewher
jacobson
et
al
epsteinbarr
viru
ebv
pool
prepar
grow
ebvproduc
cell
line
atcc
harvest
supernat
mv
hsv
virusinfect
vero
cell
monolay
harvest
sonic
use
antigen
enzymelink
immunosorb
assay
elisa
viral
titer
mv
determin
plaqu
assay
hsv
determin
tissu
cultur
infect
dose
assay
tcid
vero
cell
grown
plate
flu
grown
amniot
fluid
viral
titer
determin
hemaglutin
assay
mvspecif
fluspecif
ctl
gener
describ
previous
jacobson
et
al
stimul
mv
perform
multipl
infect
moi
stimul
flu
perform
dilut
flu
viru
titer
hemagglutin
unitsml
huml
cell
cultur
day
rpmi
medium
human
serum
supplement
glutamin
antibiot
humidifi
co
incub
hsvspecif
ctl
gener
similar
manner
howev
stimul
hsv
perform
pa
ultraviolet
inactiv
prepar
hsv
viru
origin
titer
crystal
violet
stain
hsvinfect
vero
cell
cell
cultur
day
rpmi
medium
supplement
human
serum
glutamin
antibiot
autolog
ebvtransform
bcell
line
use
target
virus
examin
experi
involv
determin
hla
restrict
hsvspecif
ctl
hlamatch
mismatch
ebvtransform
virusinfect
bcell
line
use
x
ebvtransform
bcell
infect
live
viru
follow
moi
mv
moi
flu
viru
prepar
titer
huml
hsv
xl
viru
prepar
titer
x
virusinfect
uninfect
ebvtransform
bcell
line
label
scr
incub
virusspecif
ctl
follow
effector
target
e
ratio
uninfect
autolog
ebvtransform
target
run
assay
control
nonspecif
activ
effector
stimul
medium
effector
specif
irrelev
viru
assay
virusinfect
target
control
integr
target
mvspecif
ctl
hsvinfect
target
vice
versa
percent
lysi
calcul
use
follow
formula
data
analyz
student
ttest
independ
popul
onetail
viru
specif
hsvctl
assay
fig
specif
mvctl
assay
well
fluctl
assay
establish
previou
investig
specif
hsvspecif
ctl
examin
comparison
mvspecif
ctl
fluspecif
ctl
experi
ctl
gener
mv
lyse
mvinfect
target
fail
lyse
hsvinfect
target
similarli
ctl
gener
hsv
lyse
hsvinfect
target
target
infect
mv
experi
ctl
gener
flu
lyse
fluinfect
target
hsvinfect
target
similar
viru
specif
demonstr
ci
l
gener
hsv
mvspecif
ctl
shown
previous
predominantli
restrict
class
ii
hla
molecul
jacobson
et
al
fluspecif
ctl
predominantli
restrict
class
molecul
rotteveel
et
al
investig
examin
hla
restrict
pattern
hsvspecif
ctl
assay
assay
hsvsensit
effector
allogen
bcell
target
either
match
hla
class
loci
hla
class
ii
loci
hla
mismatch
shown
fig
hsvsensit
effector
recogn
hla
class
iimatch
target
fail
recogn
either
hsvinfect
target
match
hla
class
hsvinfect
hlami
match
target
uninfect
target
contrast
class
mismatch
target
readili
kill
autolog
effectot
similar
result
hla
restrict
obtain
ctl
ms
patient
found
control
subsequ
experi
examin
hla
restrict
hsvspecif
ctl
see
fig
none
four
hlamismatch
target
four
hla
class
imatch
target
evidenc
lysi
seen
uninfect
autolog
control
contrast
hla
class
llmatch
target
well
autolog
hsvinfect
target
posit
control
readili
lyse
hsvsensit
effector
indic
hsvctl
like
mvctl
predominantli
restrict
hla
class
ii
molecul
support
observ
investig
regard
hla
class
ii
restrict
hsvspecif
ctl
yasukawa
zarl
b
mv
hsvspecif
ctl
examin
ms
patient
well
control
effector
e
ratio
shown
fig
control
popul
mean
mvspecif
ctl
valu
sd
ms
popul
mean
mvspecif
ctl
sd
p
hsv
control
popul
mean
hsvspecif
ctl
sd
ms
popul
mean
hsvspecif
ctl
sd
p
contrast
differ
control
ms
patient
percent
lysi
virusinfect
target
pbl
stimul
medium
fig
percent
lysi
virusstimul
target
assay
upon
uninfect
autolog
target
examin
relationship
mvspecif
ctl
hsvspecif
ctl
ms
patient
control
see
correl
reduc
mvspecif
ctl
reduc
hsvspecif
ctl
ms
support
gener
reduct
hla
class
iirestrict
ctl
see
tabl
none
healthi
control
reduc
gener
ctl
specif
virus
four
patient
ms
unequivoc
reduct
mvspecif
hsvspecif
ctl
addit
four
patient
total
reduct
ctl
specif
hsv
mv
reduct
ctl
gener
result
gener
impair
pbl
function
patient
insofar
fluspecif
ctl
normal
one
eight
patient
reduc
mv
hsvspecif
ctl
see
tabl
howev
correl
hsvspecif
ctl
mvspecif
ctl
either
ms
control
popul
previou
studi
patient
ms
found
reduc
gener
mvspecif
ctl
compar
healthi
neurolog
diseas
control
jacobson
et
al
contrast
gener
ctl
specif
mump
viru
influenza
viru
normal
ms
jacobson
et
al
goodman
et
al
investig
found
gener
ctl
specif
hsv
also
reduc
ms
thu
ctl
defect
previous
thought
limit
mv
extend
least
one
viru
least
two
explan
find
ms
patient
may
gener
defect
tcell
function
altern
ms
patient
may
impair
cellular
immun
number
virus
includ
necessarili
limit
mv
hsv
idea
reduc
gener
ctl
specif
mv
hsv
may
reflect
gener
impair
tcell
function
stem
observ
mv
well
hsv
induc
immun
respons
appear
predominantli
restrict
hla
class
iirestrict
ctl
ctl
thought
primarili
mediat
tcell
reduc
tcellmedi
ctl
ms
intrigu
insofar
ms
patient
repeatedli
shown
gener
elev
amount
antibodi
multipl
virus
includ
mv
hsv
norrbi
et
al
b
baig
et
al
gener
antibodi
also
depend
upon
tcell
van
binnendijk
et
al
similar
elev
antibodi
product
reduc
ctl
report
number
anim
model
autoimmun
diseas
includ
murin
graftversushost
diseas
murin
lupu
gleichmann
et
al
theofilopoulo
et
ai
moser
et
al
via
et
al
via
et
al
via
shearer
addit
reduc
mvspecif
ctl
report
patient
hamtsp
demyelin
disord
caus
htlvi
viru
similar
ms
patient
earli
asymptomat
infect
hivi
viru
respons
acquir
immunodefici
syndrom
aid
also
elev
antibodi
product
reduc
ctl
shearer
et
al
eal
et
al
intrigu
insofar
earli
hivi
infect
aid
patient
arc
suscept
autoimmun
disord
inflammatori
demyelin
polyneuropathi
thu
possibl
reduc
hla
class
llrestrict
ctl
may
predispos
patient
develop
autoimmun
diseas
might
reduct
virusspecif
hla
class
llrestrict
ctl
lead
autoimmun
diseas
suggest
hla
class
iirestrict
ctl
may
play
role
regul
immun
respons
viru
lysi
antigenpres
cell
display
viral
antigen
ottenhoff
muff
strober
jame
lysi
would
tend
limit
immun
respons
may
inhibit
gener
selfreact
clone
primari
immunoregulatori
abnorm
ms
whether
genet
acquir
result
reduc
hla
class
iirestrict
ctl
may
permit
exagger
immun
respons
upon
stimul
common
virus
exagger
immun
may
lead
expans
clone
crossreact
myelin
protein
result
demyelin
diseas
possibl
gener
abnorm
hla
class
iirestrict
ctl
might
present
ms
patient
previous
examin
relat
mump
viru
member
laboratori
investig
differ
found
mumpsspecif
ctl
assay
upon
hla
class
llrestrict
target
ms
patient
control
goodman
et
al
howev
gener
hla
class
llrestrict
ctl
ctl
respons
mark
effector
respons
mump
viru
may
difler
gener
virusspecif
ctl
respons
predominantli
hla
class
ii
restrict
tcell
report
provid
help
may
increas
gener
ctl
system
ctl
precursor
gener
regard
instruct
anim
model
autoimmun
earli
hiv
infect
ctl
defect
correct
via
shearer
studi
examin
relationship
mvspecif
ctl
hsvspecif
ctl
patient
control
group
although
mani
ms
patient
reduc
ctl
specif
hsv
mv
studi
found
signific
correl
ms
patient
reduc
mvspecif
ctl
reduc
hsvspecif
ctl
possibl
low
ctl
found
assay
system
may
reflect
gross
reduct
virusspecif
ctl
assay
may
adequ
identifi
subtl
differ
addit
overal
level
virusspecif
ctl
gener
primari
infect
thought
affect
numer
factor
gener
health
age
time
infect
thu
defect
hla
class
iirestrict
ctl
could
escap
detect
small
sampl
given
presenc
variabl
influenc
ctl
gener
altern
explan
reduc
mv
hsvspecif
ctl
found
ms
ms
patient
may
abnorm
infect
neurotrop
virus
mv
hsv
abnorm
infect
may
reflect
variou
factor
includ
genet
background
viral
strain
age
time
initi
exposur
viru
abnorm
infect
viru
might
initi
ms
either
result
viral
persist
mimicri
neural
antigen
disord
immun
regul
mv
known
result
persist
infect
subacut
scleros
panenceph
sspe
disord
patient
elev
titer
mvspecif
antibodi
reduc
mvspecif
ctl
similar
found
ms
dhibjalbut
et
al
postul
reduc
mvspecif
ctl
sspe
may
contribut
viral
persist
affect
patient
howev
genet
materi
hybrid
mvspecif
probe
found
ms
well
control
brain
hass
et
al
unlik
sspe
repeat
attempt
isol
live
viru
ms
brain
fail
weigh
hypothesi
viral
persist
ms
similarli
exampl
molecular
mimicri
exist
fujinami
oldston
seem
unlik
explan
induct
ms
either
mv
hsv
virus
may
initi
autoimmun
diseas
clear
anim
model
demyelin
diseas
caus
viru
infect
mv
well
coronaviru
lewi
rat
result
gener
tcell
prolifer
respons
myelin
basic
protein
mbp
watanab
et
al
liebert
et
al
follow
expans
vitro
mbpspecif
tcell
transfer
experiment
allerg
enceph
similar
antimbp
respons
report
human
follow
mv
enceph
johnson
et
al
possibl
individu
reduc
cellular
immun
viru
may
suscept
central
nervou
system
cn
involv
upon
infect
common
virus
cn
involv
may
lead
sensit
myelin
antigen
ms
patient
without
viral
persist
repeat
exposur
activ
viru
may
result
induct
delayedtyp
hypersensit
respons
direct
myelin
antigen
subsequ
demyelin
diseas
